The Australian Competition and Consumer Commission (ACCC) has announced it will grant authorization for edition 17 of Medicines Australia’s Code of Conduct for three years.

 

The Code regulates interactions between member companies and healthcare professionals, such as doctors and pharmacists.

 

“The ACCC considers that the Code results in public benefits by providing greater transparency around the relationships between pharmaceutical companies and healthcare professionals,” ACCC Chairman Rod Sims said.

 

“However, the ACCC notes that community expectations of disclosure by the pharmaceutical industry have increased and continue to increase. In light of this, the ACCC considers Medicines Australia could go further in ensuring the Code meets these expectations now and in the future.”

 

The ACCC is now seeking submissions from the applicant and interested parties on the draft determination. The draft determination is available at www.accc.gov.au/AuthorisationsRegister